Draft 340B reforms include user fees, clarity around contract pharmacies
Six bipartisan senators suggested several changes to improve the “stability and transparency” of the 340B drug discount program in a long-awaited draft bill released Friday.
The 340B program requires drug manufacturers to offer discounts to certain health systems and hospitals serving low-income populations. But lawmakers have accused some systems of abusing the growing program, while pharma companies have set their own limits around participation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.